{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:42:54Z","timestamp":1769157774678,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T00:00:00Z","timestamp":1262217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10549-009-0690-9","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T07:10:44Z","timestamp":1262157044000},"page":"471-481","source":"Crossref","is-referenced-by-count":15,"title":["Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis"],"prefix":"10.1007","volume":"122","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,31]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1383-5742(00)00018-1","volume":"462","author":"VN Kristensen","year":"2000","unstructured":"Kristensen VN, Borresen-Dale AL (2000) Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutat Res 462:323\u2013333","journal-title":"Mutat Res"},{"key":"690_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/oxfordjournals.jncimonographs.a024235","volume":"27","author":"PA Thompson","year":"2000","unstructured":"Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27:125\u2013134","journal-title":"J Natl Cancer Inst Monogr"},{"key":"690_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"690_CR4","first-page":"741","volume":"8","author":"JL Hopper","year":"1999","unstructured":"Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomark Prev 8:741\u2013747","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1440-1622.1999.01515.x","volume":"69","author":"IC Bennett","year":"1999","unstructured":"Bennett IC, Gattas M, Teh BT (1999) The genetic basis of breast cancer and its clinical implications. Aust N Z J Surg 69:95\u2013105","journal-title":"Aust N Z J Surg"},{"key":"690_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H","volume":"88","author":"MC Johnson-Thompson","year":"2000","unstructured":"Johnson-Thompson MC, Guthrie J (2000) Ongoing research to identify environmental risk factors in breast carcinoma. Cancer 88:1224\u20131229","journal-title":"Cancer"},{"key":"690_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/dna.1987.6.439","volume":"6","author":"J Picado-Leonard","year":"1987","unstructured":"Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase\/17, 20 lyase): similarity with the gene for P450c21. DNA 6:439\u2013448","journal-title":"DNA"},{"key":"690_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0950-351X(98)80461-8","volume":"12","author":"WL Miller","year":"1998","unstructured":"Miller WL (1998) Early steps in androgen biosynthesis: from cholesterol to DHEA. Baillieres Clin Endocrinol Metab 12:67\u201381","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"690_CR9","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","volume":"3","author":"AH Carey","year":"1994","unstructured":"Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873\u20131876","journal-title":"Hum Mol Genet"},{"key":"690_CR10","first-page":"1063","volume":"57","author":"HS Feigelson","year":"1997","unstructured":"Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063\u20131065","journal-title":"Cancer Res"},{"key":"690_CR11","first-page":"585","volume":"58","author":"HS Feigelson","year":"1998","unstructured":"Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE (1998) Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 58:585\u2013587","journal-title":"Cancer Res"},{"key":"690_CR12","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/bjc.1998.340","volume":"77","author":"AM Dunning","year":"1998","unstructured":"Dunning AM, Healey CS, Pharoah PD, Foster NA, Lipscombe JM, Redman KL et al (1998) No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer 77:2045\u20132047","journal-title":"Br J Cancer"},{"key":"690_CR13","first-page":"945","volume":"7","author":"KJ Helzlsouer","year":"1998","unstructured":"Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA (1998) Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomark Prev 7:945\u2013949","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR14","first-page":"941","volume":"7","author":"A Weston","year":"1998","unstructured":"Weston A, Pan CF, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS (1998) CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomark Prev 7:941\u2013944","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR15","first-page":"1015","volume":"59","author":"CA Haiman","year":"1999","unstructured":"Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE et al (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015\u20131020","journal-title":"Cancer Res"},{"key":"690_CR16","first-page":"4870","volume":"59","author":"CS Huang","year":"1999","unstructured":"Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870\u20134875","journal-title":"Cancer Res"},{"key":"690_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1349-7006.2000.tb01029.x","volume":"91","author":"N Hamajima","year":"2000","unstructured":"Hamajima N, Iwata H, Obata Y, Matsuo K, Mizutani M, Iwase T et al (2000) No association of the 5\u2032 promoter region polymorphism of CYP17 with breast cancer risk in Japan. Jpn J Cancer Res 91:880\u2013885","journal-title":"Jpn J Cancer Res"},{"key":"690_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3835(00)00436-5","volume":"156","author":"ES Kuligina","year":"2000","unstructured":"Kuligina ES, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisskiy KM, Chagunava OL et al (2000) CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. Cancer Lett 156:45\u201350","journal-title":"Cancer Lett"},{"key":"690_CR19","first-page":"1343","volume":"9","author":"K Mitrunen","year":"2000","unstructured":"Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S et al (2000) Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomark Prev 9:1343\u20131348","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR20","first-page":"785","volume":"61","author":"HS Feigelson","year":"2001","unstructured":"Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE (2001) Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res 61:785\u2013789","journal-title":"Cancer Res"},{"key":"690_CR21","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/bcr570","volume":"5","author":"CB Ambrosone","year":"2003","unstructured":"Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S et al (2003) CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Res 5:R45\u2013R51","journal-title":"Breast Cancer Res"},{"key":"690_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.bjc.6600839","volume":"88","author":"K Gudmundsdottir","year":"2003","unstructured":"Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE (2003) CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Br J Cancer 88:933\u2013936","journal-title":"Br J Cancer"},{"key":"690_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ijc.10957","volume":"104","author":"AH Wu","year":"2003","unstructured":"Wu AH, Seow A, Arakawa K, Van Den Berg D, Lee HP, Yu MC (2003) HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer 104:450\u2013457","journal-title":"Int J Cancer"},{"key":"690_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/BF02968046","volume":"11","author":"P Chacko","year":"2004","unstructured":"Chacko P, Rajan B, Mathew BS, Joseph T, Pillai MR (2004) CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 11:380\u2013388","journal-title":"Breast Cancer"},{"key":"690_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/cncr.20361","volume":"101","author":"LA Hefler","year":"2004","unstructured":"Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G et al (2004) Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 101:264\u2013269","journal-title":"Cancer"},{"key":"690_CR26","doi-asserted-by":"publisher","first-page":"R513","DOI":"10.1186\/bcr1040","volume":"7","author":"JH Chang","year":"2005","unstructured":"Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL et al (2005) CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 7:R513\u2013R521","journal-title":"Breast Cancer Res"},{"key":"690_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/emm.2005.2","volume":"37","author":"MH Shin","year":"2005","unstructured":"Shin MH, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY et al (2005) Genetic polymorphism of CYP17 and breast cancer risk in Korean women. Exp Mol Med 37:11\u201317","journal-title":"Exp Mol Med"},{"key":"690_CR28","first-page":"1507","volume":"118","author":"DF Han","year":"2005","unstructured":"Han DF, Zhou X, Hu MB, Xie W, Mao ZF, Chen DE et al (2005) Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study. Chin Med J 118:1507\u20131516","journal-title":"Chin Med J"},{"key":"690_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10038-006-0095-0","volume":"52","author":"A Chakraborty","year":"2007","unstructured":"Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S (2007) CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J Hum Genet 52:159\u2013165","journal-title":"J Hum Genet"},{"key":"690_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/carcin\/bgn042","volume":"29","author":"Y Chen","year":"2008","unstructured":"Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S et al (2008) Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 29:766\u2013771","journal-title":"Carcinogenesis"},{"key":"690_CR31","first-page":"111","volume":"10","author":"M Samson","year":"2009","unstructured":"Samson M, Rama R, Swaminathan R, Sridevi V, Nancy KN, Rajkumar T (2009) CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women. Asian Pac J Cancer Prev 10:111\u2013114","journal-title":"Asian Pac J Cancer Prev"},{"key":"690_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10549-008-9998-0","volume":"114","author":"L Zhang","year":"2009","unstructured":"Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K (2009) Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat 114:327\u2013338","journal-title":"Breast Cancer Res Treat"},{"key":"690_CR33","first-page":"843","volume":"8","author":"AM Dunning","year":"1999","unstructured":"Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomark Prev 8:843\u2013854","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/mutage\/17.2.119","volume":"17","author":"Z Ye","year":"2002","unstructured":"Ye Z, Parry JM (2002) The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17:119\u2013126","journal-title":"Mutagenesis"},{"key":"690_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/mutage\/17.5.445","volume":"17","author":"HS Feigelson","year":"2002","unstructured":"Feigelson HS, McKean-Cowdin R, Henderson BE (2002) Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17:445\u2013446 (author reply 7\u20138)","journal-title":"Mutagenesis"},{"key":"690_CR36","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/jnci\/92.20.1674","volume":"92","author":"AB Spurdle","year":"2000","unstructured":"Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR et al (2000) CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 92:1674\u20131681","journal-title":"J Natl Cancer Inst"},{"key":"690_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO;2-L","volume":"84","author":"M Bergman-Jungestrom","year":"1999","unstructured":"Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350\u2013353","journal-title":"Int J Cancer"},{"key":"690_CR38","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.meegid.2009.09.010","volume":"9","author":"Y Chen","year":"2009","unstructured":"Chen Y, Pei J (2009) An assessment of a TNF polymorphic marker for the risk of HCV infection: meta-analysis and a new clinical study design. Infect Genet Evol 9:1356\u20131363","journal-title":"Infect Genet Evol"},{"key":"690_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1742-1241.2009.02168.x","volume":"63","author":"WL Baker","year":"2009","unstructured":"Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI (2009) Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract 63:1426\u20131434","journal-title":"Int J Clin Pract"},{"key":"690_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2407-9-115","volume":"9","author":"C Antognelli","year":"2009","unstructured":"Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crino L et al (2009) CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case\u2013control study. BMC Cancer 9:115","journal-title":"BMC Cancer"},{"key":"690_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0895-4356(03)00011-8","volume":"56","author":"J Attia","year":"2003","unstructured":"Attia J, Thakkinstian A, D\u2019Este C (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56:297\u2013303","journal-title":"J Clin Epidemiol"},{"key":"690_CR42","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/ije\/dyi169","volume":"34","author":"C Minelli","year":"2005","unstructured":"Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34:1319\u20131328","journal-title":"Int J Epidemiol"},{"key":"690_CR43","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"690_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"690_CR45","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"690_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2307\/2347570","volume":"41","author":"BP Carlin","year":"1992","unstructured":"Carlin BP, Galfand AE, Smith AFM (1992) Hierarchical Bayesian analysis of changepoint problems. Appl Stat 41:389\u2013408","journal-title":"Appl Stat"},{"key":"690_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/01621459.1993.10594284","volume":"88","author":"NE Breslow","year":"1993","unstructured":"Breslow NE, Clayton DG (1993) Approximate inference in generalized linear mixed models. J Am Stat Assoc 88:9\u201325","journal-title":"J Am Stat Assoc"},{"key":"690_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-1-4419-9019-8_23","volume":"537","author":"RC Boston","year":"2003","unstructured":"Boston RC, Sumner AE (2003) STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol 537:353\u2013369","journal-title":"Adv Exp Med Biol"},{"key":"690_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105\u2013114","journal-title":"Contemp Clin Trials"},{"key":"690_CR50","volume-title":"Winbugs user manual","author":"D Spiegelhalter","year":"2003","unstructured":"Spiegelhalter D, Thomas A, Best N, Lunn D (2003) Winbugs user manual. MRC Biostatistics Unit, Cambridge"},{"key":"690_CR51","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/jn\/136.6.1596","volume":"136","author":"R Piller","year":"2006","unstructured":"Piller R, Verla-Tebit E, Wang-Gohrke S, Linseisen J, Chang-Claude J (2006) CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans. J Nutr 136:1596\u20131603","journal-title":"J Nutr"},{"key":"690_CR52","doi-asserted-by":"publisher","first-page":"R455","DOI":"10.1186\/bcr1027","volume":"7","author":"E Verla-Tebit","year":"2005","unstructured":"Verla-Tebit E, Wang-Gohrke S, Chang-Claude J (2005) CYP17 5\u2032-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study. Breast Cancer Res 7:R455\u2013R464","journal-title":"Breast Cancer Res"},{"key":"690_CR53","doi-asserted-by":"publisher","first-page":"R890","DOI":"10.1186\/bcr1319","volume":"7","author":"K Einarsdottir","year":"2005","unstructured":"Einarsdottir K, Rylander-Rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E et al (2005) CYP17 gene polymorphism in relation to breast cancer risk: a case-control study. Breast Cancer Res 7:R890\u2013R896","journal-title":"Breast Cancer Res"},{"key":"690_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.bjc.6690663","volume":"81","author":"IE Young","year":"1999","unstructured":"Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB et al (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141\u2013143","journal-title":"Br J Cancer"},{"key":"690_CR55","first-page":"139","volume":"16","author":"DV Spicer","year":"1994","unstructured":"Spicer DV, Pike MC (1994) Sex steroids and breast cancer prevention. J Natl Cancer Inst Monogr 16:139\u2013147","journal-title":"J Natl Cancer Inst Monogr"},{"key":"690_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/01.GIM.0000151839.12032.1A","volume":"7","author":"G Salanti","year":"2005","unstructured":"Salanti G, Sanderson S, Higgins JP (2005) Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7:13\u201320","journal-title":"Genet Med"},{"key":"690_CR57","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/sim.1410","volume":"22","author":"IS Nam","year":"2003","unstructured":"Nam IS, Mengersen K, Garthwaite P (2003) Multivariate meta-analysis. Stat Med 22:2309\u20132333","journal-title":"Stat Med"},{"key":"690_CR58","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/sim.1040","volume":"21","author":"HC Houwelingen van","year":"2002","unstructured":"van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21:589\u2013624","journal-title":"Stat Med"},{"key":"690_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/01632780122034867","volume":"24","author":"CH Schmid","year":"2001","unstructured":"Schmid CH (2001) Using Bayesian inference to perform meta-analysis. Eval Health Prof 24:165\u2013189","journal-title":"Eval Health Prof"},{"key":"690_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2350-9-55","volume":"9","author":"BN Tran","year":"2008","unstructured":"Tran BN, Nguyen ND, Eisman JA, Nguyen TV (2008) Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. BMC Med Genet 9:55","journal-title":"BMC Med Genet"},{"key":"690_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00052137","volume":"2","author":"L Bernstein","year":"1991","unstructured":"Bernstein L, Pike MC, Ross RK, Henderson BE (1991) Age at menarche and estrogen concentrations of adult women. Cancer Causes Control 2:221\u2013225","journal-title":"Cancer Causes Control"},{"key":"690_CR62","first-page":"563","volume":"10","author":"MT Goodman","year":"2001","unstructured":"Goodman MT, McDuffie K, Guo C, Terada K, Donlon TA (2001) CYP17 genotype and ovarian cancer: a null case-control study. Cancer Epidemiol Biomark Prev 10:563\u2013564","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR63","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1158\/1055-9965.EPI-04-0197","volume":"14","author":"NC Onland-Moret","year":"2005","unstructured":"Onland-Moret NC, van Gils CH, Roest M, Grobbee DE, Peeters PH (2005) Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomark Prev 14:815\u2013820","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"690_CR64","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/ijc.24494","volume":"125","author":"S Butt","year":"2009","unstructured":"Butt S, Borgquist S, Anagnostaki L, Landberg G, Manjer J (2009) Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. Int J Cancer 125:1926\u20131934","journal-title":"Int J Cancer"},{"key":"690_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-59745-416-2_3","volume":"471","author":"CH Yip","year":"2009","unstructured":"Yip CH (2009) Breast cancer in Asia. Methods Mol Biol 471:51\u201364","journal-title":"Methods Mol Biol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0690-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0690-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T12:06:56Z","timestamp":1739707616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,31]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0690-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,31]]}}}